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Background: Pseudomonas aeruginosa is an important nosocomial pathogen that exhibits multiple resistances to
antibiotics with increasing frequency, making patient treatment more difficult. The aim of the study is to ascertain
the population structure of this clinical pathogen in the Hospital Son Llàtzer, Spain.
Results: A significant set (56) of randomly selected clinical P. aeruginosa isolates, including multidrug and non-
multidrug resistant isolates, were assigned to sequence types (STs) and compared them with their antibiotic
susceptibility profile classified as follows: extensively drug resistant (XDR), multidrug resistant (MDR) and non-
multidrug resistant (non-MDR). The genetic diversity was assessed by applying the multilocus sequence typing
(MLST) scheme developed by Curran and collaborators, and by the phylogenetic analysis of a concatenated tree.
The analysis of seven loci, acsA, aroE, guaA, mutL, nuoD, ppsA and trpE, demonstrated that the prevalent STs were
ST-175, ST-235 and ST-253. The majority of the XDR and MDR isolates were included in ST-175 and ST-235. ST-253 is
the third in frequency and included non-MDR isolates. The 26 singleton sequence types corresponded mainly to
non-MDR isolates. Twenty-two isolates corresponded to new sequence types (not previously defined) of which 12
isolates were non-MDR and 10 isolates were MDR or XDR.
Conclusions: The population structure of clinical P. aeruginosa present in our hospital indicates the coexistence of
nonresistant and resistant isolates with the same sequence type. The multiresistant isolates studied are grouped in
the prevalent sequence types found in other Spanish hospitals and at the international level, and the susceptible
isolates correspond mainly to singleton sequence types.
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Population structureBackground
Pseudomonas aeruginosa is a non-fermenting Gram-
negative bacterium that is widely distributed in nature.
The minimum nutritional requirements, tolerance to a
wide variety of physical conditions and intrinsic resist-
ance against many antibiotics explain its role as an
important nosocomial pathogen. Certain bacterial clones
have been distributed worldwide and, in most cases, as-
sociated with multiresistance patterns [1-3]. Because the
number of active antibiotics against P. aeruginosa is lim-
ited, it is a priority to perform a strict and regular follow
up of the resistance patterns in individual hospitals.* Correspondence: marga.gomila@uib.es
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reproduction in any medium, provided the orIn the microbiology laboratory of the Hospital
Son Llàtzer (Mallorca, Spain) the number of isolates of
P. aeruginosa is increasing annually. In 2010, the
number of isolates of P. aeruginosa was 1174, being the
second pathogen isolated after Escherichia coli. When
the P. aeruginosa resistance pattern of the P. aeruginosa
isolates from this hospital were compared with the latest
Spanish surveillance study of antimicrobial resistance
[4], it was revealed that the resistance levels of the
isolates in our hospital were higher against all of the
antibiotics commonly used in the treatment of infections
caused by P. aeruginosa, contributing to therapeutic
difficulties.
The introduction of molecular techniques has led to
significant progress in both bacterial identification and
typing. In P. aeruginosa, several schemes for molecularLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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based fingerprinting [6], or pulsed-field gel electrophor-
esis (PFGE) [7], which is considered the ‘gold standard’
technique. Curran et al. (2004) developed a multilocus
sequence typing (MLST) scheme that discriminates
P. aeruginosa isolates by differences in the sequences of
seven genes: acsA, aroE, guaA, mutL, nuoD, ppsA and
trpE, providing a good comprehensive database that
allows the comparison of results obtained in different
locations for different sample types [8]. Since this work,
MLST has been applied in several studies of P. aeruginosa
to better understand the epidemiology of infections in
patients with cystic fibrosis and to study multiresistant
clones.
The main objective of our study is to characterise the
isolates of P. aeruginosa analysed routinely in the
Hospital Son Llàtzer at the molecular level. A significant
set of randomly selected clinical isolates (fifty-six),
including multidrug and non-multidrug resistant iso-
lates, was further studied to determine the population
structure of this clinical pathogen in our hospital and to
compare it with other Spanish and international
multicentre surveillance studies.
Methods
P. aeruginosa culture collection
A total of 56 isolates of P. aeruginosa from 53 specimens
recovered from 42 patients of the Hospital Son Llàtzer
were randomly selected between January and February
2010. Three samples showed two distinct colony morph-
ologies, and both types of each isolate were studied by
MLST to establish possible differences between them
(these morphologies are labelled by the number of the
isolate, followed by the letters a or b). Isolates from dif-
ferent origins were taken as part of standard care
(Table 1). The hospital is a tertiary teaching hospital
with 377 beds and serves a catchment population of ap-
proximately 250,000 inhabitants. All of the P. aeruginosa
isolates were isolated and cultured on Columbia agar
with 5% sheep blood (bioMérieux, Marcy d’Etoile,
France). The cultivation and incubation times of the
plates were performed under routine laboratory condi-
tions (24 h at 37°C). The study was approved by the re-
search board of our hospital. Individual patient’s consent
was not sought as isolates were derived from routine
diagnostics and as data were processed anonymously.
Phenotypic and antibiotic susceptibility characterisations
The 56 isolates were biochemically and phenotypically
characterised using the authomatized VITEK®2 GN
method (bioMériux, Marcy d’Etoile, France) and the oxi-
dase reaction test. Their antibiogram profiles were
established by the disk diffusion method on Mueller-
Hinton agar plates (bioMérieux, Marcy d’Etoile, France)following CLSI recommendations for all antibiotics,
except for fosfomycin which followed the French
Microbiology Society recommendations [9,10]. Borderline
values were assessed by the E-test method (bioMérieux,
Marcy d’Etoile, France). The antibiotics tested were
amikacin, aztreonam, cefepime, ceftazidime, ciprofloxacin,
colistin, gentamicin, fosfomycin, imipenem, levofloxacin,
meropenem, piperacillin-tazobactam and tobramycin. For
the isolates resistant to imipenem and/or meropenem, the
determination of metallo-β-lactamases (MBLs) using
E-test strips with Imipenem-EDTA was performed
(bioMérieux, Marcy d’Etoile, France). The classification of
multiresistance was performed according to Magiorakos
et al. [11]. The isolates were classified according to the
resistance pattern as multidrug resistant (MDR, non-
susceptible to at least one agent in three or more anti-
microbial categories), extensively drug resistant (XDR,
non-susceptible to at least one agent in all but two or
fewer antimicrobial categories; i.e. bacterial isolates remain
susceptible to only one or two categories), pandrug-
resistant (PDR, non-susceptible to all agents in all
antimicrobial categories), and non-multidrug resistant
(non-MDR).
DNA extraction: PCR amplification and DNA sequencing
Bacterial genomic DNA for PCR amplification was
obtained as previously described [12]. The housekeeping
genes acsA, aroE, guaA, mutL, nuoD, ppsA and trpE
were amplified and sequenced for the 56 isolates using
the primers described previously [8]. The PCR condi-
tions have been slightly modified. The reactions were
performed using an Eppendorf thermocycler, with an
initial denaturation step at 96°C 2 min, followed by
35 cycles of denaturation at 96°C for 1 min for all of the
genes, a primer annealing temperature, depending on
the gene (55–58°C for aroE and nuoD; 58°C for acsA
and guaA; and 58–60°C for mutL, ppsA and trpE), for
1 min and a primer extension at 72°C for 1 min for all
of the genes, with the exception of aroE (1.5 min). A
final elongation step was performed at 72°C for 10 min.
The PCR amplification reactions were performed as
previously described [12]. The amplified products were
purified with Multiscreen HTS PCR 96-well filter plates
(Millipore). Sequence reactions were carried out using
the ABI Prism BigDye Terminator version 3.1 and
the sequences were read with an automatic sequence
analyser (3130 genetic analyzer; Applied Biosystems).
Sequence analysis and allele and nucleotide diversity
Sequence analysis was performed as described previously
[12]. Individual phylogenetic trees and concatenated ana-
lyses of the sequenced gene fragments were constructed
[12]. The allelic and nucleotide diversities were calculated
from the gene sequences using the DnaSP package,
Table 1 List of the alleles and sequence type, origin of the sample, antibiotic pattern and number of patient for each
isolate
Isolates Patient Sample origina STs acsA aroE guaA mutL nuoD ppsA trpE Antibiotic patternb
PaC1 1 W ST-1138* 5 3 79 5 1 7 47 XDR
PaC49 1 RS ST-1191* 45 148* 15 35 53 106* 3 MDR
PaC51 1 RS ST-1147* 17 3 5 3 1 6 26 non-MDR
PaC52 1 W ST-1138* 5 3 79 5 1 7 47 XDR
PaC2 2 W ST-175 28 22 5 3 3 14 19 XDR
PaC3 3 R ST-235 38 11 3 13 1 2 4 non-MDR
PaC4 4 R ST-800 17 22 11 3 3 15 3 non-MDR
PaC5 5 W ST-108 39 5 20 5 1 6 31 XDR
PaC7 6 R New-1 28 5 36 - 3 13 7 MDR
PaC16 6 R New-2 28 5 20 - 3 13 7 MDR
PaC9 7 U ST-274 23 5 11 7 1 12 7 XDR
PaC10 8 U ST-1139* 28 22 20 3 3 14 19 XDR
PaC19 8 U ST-175 28 22 5 3 3 14 19 XDR
PaC32 8 RS ST-175 28 22 5 3 3 14 19 XDR
PaC40 8 R ST-175 28 22 5 3 3 14 19 XDR
PaC11 9 U ST-235 38 11 3 13 1 2 4 XDR
PaC24 9 U ST-235 38 11 3 13 1 2 4 XDR
PaC12 10 R ST-1140* 38 11 20 13 1 2 4 XDR
PaC14 11 R ST-1141* 113 4 5 67 1 17 26 non-MDR
PaC15 12 R ST-1142* 35 11 112 16 1 6 42 MDR
PaC17 13 R ST-1186* 39 5 20 59* 1 20 15 non-MDR
PaC18a 14 U ST-1143* 8 5 9 3 1 4 9 non-MDR
PaC18b 14 U ST-1143* 8 5 9 3 1 4 9 non-MDR
PaC20 15 U ST-1144* 39 10 1 3 4 6 7 non-MDR
PaC21 16 R ST-175 28 22 5 3 3 14 19 XDR
PaC23 17 U ST-1187* 35 22 5 3 1 104* 4 non-MDR
PaC25a 18 U ST-207 47 4 5 33 1 6 40 non-MDR
PaC25b 18 U ST-207 47 4 5 33 1 6 40 non-MDR
PaC26 19 R ST-235 38 11 3 13 1 2 4 XDR
PaC27 20 R ST-274 23 5 11 7 1 12 7 non-MDR
PaC28 21 U ST-1188* 69* 147* 5 11 2 15 2 MDR
PaC29 22 R ST-1145* 15 5 1 1 1 12 1 non-MDR
PaC30 23 PS ST-244 17 5 12 3 14 4 7 non-MDR
PaC31 24 U ST-499 11 5 7 27 2 7 33 MDR
PaC33 25 R ST-175 28 22 5 3 3 14 19 XDR
PaC34 26 R ST-179 36 27 28 3 4 13 7 MDR
PaC35 27 U ST-235 38 11 3 13 1 2 4 MDR
PaC36a 28 R ST-175 28 22 5 3 3 14 19 XDR
PaC36b 28 R ST-175 28 22 5 3 3 14 19 MDR
PaC37 29 B ST-175 28 22 5 3 3 14 19 XDR
PaC38 29 B ST-175 28 22 5 3 3 14 19 XDR
PaC39 30 U ST-508 15 5 11 3 2 4 3 non-MDR
PaC41 31 U ST-1189* 72* 5 11 72 3 105* 3 non-MDR
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Table 1 List of the alleles and sequence type, origin of the sample, antibiotic pattern and number of patient for each
isolate (Continued)
PaC42 32 W ST-253 4 4 16 12 1 6 3 MDR
PaC56 32 B ST-253 4 4 16 12 1 6 3 MDR
PaC43 33 R ST-235 38 11 3 13 1 2 4 XDR
PaC44 34 U ST-316 13 8 9 3 1 6 9 non-MDR
PaC45 35 U ST-175 28 22 5 3 3 14 19 XDR
PaC46 36 R ST-1190* 45 148* 15 35 53 106* 19 MDR
PaC47 37 R ST-175 28 22 5 3 3 14 19 XDR
PaC48 38 R ST-253 4 4 16 12 1 6 3 non-MDR
PaC54 38 R ST-253 4 4 16 12 1 6 3 non-MDR
PaC50 39 US ST-1146* 5 11 57 33 1 6 3 non-MDR
PaC53 40 U ST-1148* 16 5 12 3 2 1 18 non-MDR
PaC55 41 R ST-179 36 27 28 3 4 13 7 non-MDR
PaC57 42 R ST-1149* 18 11 57 5 1 20 26 non-MDR
Asterisk mark (*) indicates the new alleles, new alleles combinations, and new sequence types described in this study. -, gene not amplified/sequenced.
aSample origin: blood (B), wound (W), urine (U), respiratory (R), rectal smear (RS), urethral smear (US), prepuce smear (PS).
bThe isolates were classified according to the resistance pattern, as multidrug-resistant (MDR, non-susceptible to ≥1 agent in ≥3 antibiotic categories), extensively
drug-resistant (XDR, non-susceptible to ≥ 1 agent in all but ≤2 antibiotic categories) and non-multidrug resistant (non-MDR).
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alleles obtained at each locus defined its allelic profile or
sequence type (ST). The ST and allele assignment were
performed at the P. aeruginosa MLST website (http://
pubmlst.org/paeruginosa/). If a sequence did not match
with an existing locus in the database, it was designated as
a “new” allele. Moreover, the new STs that did not match
any allele combination in the database were also num-
bered as “new”. The clustering of the STs and the split
decomposition were performed as previously described
[12]. The new nucleotide sequences of each different allele
of each locus determined in this study and the new
sequence types were sent to curator Eleanor Pinnock for
introduction into the P. aeruginosa MLST website (http://
pubmlst.org/paeruginosa/).
The diversity and rarefaction indexes for the statistical
analysis were calculated using the PAST v.2.0 program
[14]. The coverage index (C) was calculated as C = 1 -
(n/N), with n being the number of sequence types, and N
the number of strains analysed.
Results
Description of the bacterial isolates
In total, 227 P. aeruginosa isolates were obtained from
145 patients between January and February 2010. The
antibiotic resistance patterns for the isolates were 21.4%
XRD, 17.2% MRD and 61.4% non-MRD. In total, 56
P. aeruginosa isolates from 53 specimens were randomly
chosen from the different groups of antibiotic resistance
and further studied. Three of them showed two different
colony morphologies, and both types were studied by
MLST. The isolates were classified according to theresistance pattern as 21.4% MDR, 37.5% XDR and 41.1%
non-MDR. The antibiotic pattern and the individual
profiles are shown in Table 2.
MLST analysis
A total of 2,882 nucleotides were analysed for the 56
isolates: 390 bp for acsA, 498 for aroE, 373 bp for guaA,
442 bp for mutL, 366 bp for nuoD, 370 bp for ppsA and
443 bp for trpE. The number of polymorphic sites in the
seven loci studied varied from 69 (aroE) to 11 (nuoD) in
the 56 isolates studied. The number of alleles oscillated
from 20 for acsA to 6 for nuoD. The guaA and trpE
genes exhibited 15 different alleles, mutL and ppsA
exhibited 14 different alleles and aroE exhibited 10
different alleles. The allelic and nucleotide diversity are
shown in Table 3. The acsA, aroE, mutL and ppsA genes
displayed new alleles not previously described. The
three isolates with two different colony morphologies
presented the same allelic profile, although one of them
(PaC36a and PaC36b) had different antibiotic suscepti-
bility profiles. The allelic profile for the different isolates
and for each gene analysed are given in Table 1. The
new alleles and the new sequence types not previously
described are indicated with an asterisk mark. The
MLST analysis of the 56 isolates showed 32 different
sequence types.
Individual phylogenetic trees for each gene were
constructed and, to build a more robust phylogeny, a
concatenated analysis considering the seven genes was
also performed (Figure 1). Two isolates with mucoid
phenotype, PaC7 and PaC16, both isolated from the
same patient (number 6), were not included in the
Table 2 Susceptibility antibiotic pattern for each Pseudomonas aeruginosa isolate analysed
ANTIBIOTICSb
Strain Antibiotic patterna AMK GEN TOB IMP MEM CAZ FEP CIP LVX ATM TZP COL FOS IMP-EDTA
PaC1 XDR S S S R R R R R R R R S R Neg
PaC49 MDR S S S R R I R S S R S S S Neg
PaC51 non-MDR S S S R R S S S S S S S R Neg
PaC52 XDR S I S R R R R R R R R S R Neg
PaC2 XDR S R R R R R R R R I R S R Neg
PaC3 non-MDR S S S S S S S R R S S S R -
PaC4 non-MDR S I S S S S S S S S S S S -
PaC5 XDR S S S R R R R S I R R S R Neg
PaC7 MDR S S S R R R R R R R R S S Neg
PaC16 MDR S S S R I R R R R R R S S Neg
PaC9 XDR S I S R R S R R R R S S R Neg
PaC10 XDR S R R R R R R R R I R S R Neg
PaC19 XDR S R R R R R R R R S R S R Neg
PaC32 XDR S R R R R R R R R I R S R Neg
PaC40 XDR S R R R R R R R R S R S R Neg
PaC11 XDR R R R S S R R R R R R S R Neg
PaC24 XDR R R R S S R R R R R R S R Neg
PaC12 XDR S R R R R R R R R R R S R Pos
PaC14 non-MDR S I S S S S S S S S S S R -
PaC15 MDR S I S S S S S S S I S S R -
PaC17 non-MDR S S S S S S S S S S S S R -
PaC18a non-MDR S I S S S S S S S S S S R -
PaC18b non-MDR S S S S S S S S S S S S R -
PaC20 non-MDR S S S S S S S S S S S S R -
PaC21 XDR S R R R R R R R R R R S R Neg
PaC23 non-MDR S S S S S S S S S S S S S -
PaC25a non-MDR S S S S S S S S S S S S R -
PaC25b non-MDR S S S S S S S S S S S S R -
PaC26 XDR R R R R R R R R R R R S R Neg
PaC27 non-MDR S S S R S S S S S S S S R Neg
PaC28 MDR S S S S S S S R S R S S R Neg
PaC29 non-MDR S S S S S S S S S S S S R -
PaC30 non-MDR S S S S S S S S S S S R S -
PaC31 MDR S S S R R S S R R R S S R Neg
PaC33 XDR R R R R R R R R R R R S R Neg
PaC34 MDR R R R R R R R R R S R S S Pos
PaC35 MDR I R R R R R R R R S R S S Pos
PaC36a XDR S R R R R R R R R R R S R Neg
PaC36b MDR S R R R R S S R R S R S R Neg
PaC37 XDR S R S R R R R R R R R S R Neg
PaC38 XDR S R R R R R R R R R R S R Pos
PaC39 non-MDR S S S S S S S S S S S S R -
PaC41 non-MDR S S S S S S S S S S S S S -
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Table 2 Susceptibility antibiotic pattern for each Pseudomonas aeruginosa isolate analysed (Continued)
PaC42 MDR S S S R R R R S S R R S R Neg
PaC56 MDR S S S R R R R S S R S S R Neg
PaC43 XDR S R R R R R R R R S R S R Pos
PaC44 non-MDR S I S S S S S S S S S S R -
PaC45 XDR S R R R R R R R R R R S R Neg
PaC46 MDR S S S R R I S S R S S S S Neg
PaC47 XDR S R R R R R R R R S R S R Neg
PaC48 non-MDR S S S S S S S S S S S S R -
PaC54 non-MDR S S S S S S S S S S S S R -
PaC50 non-MDR S S S S S S S S S S S S R Neg
PaC53 non-MDR S S S S S S S S S S S S R -
PaC55 non-MDR S S S R R I S S S S S S S Neg
PaC57 non-MDR S S S S S S S S S S S S R -
aThe isolates were classified according to the resistance pattern, as multidrug-resistant (MDR, non-susceptible to ≥1 agent in ≥3 antibiotic categories), extensively
drug-resistant (XDR, non-susceptible to ≥1 agent in all but ≤2 antibiotic categories) and non-multidrug resistant (non-MDR).
bAntibiotics tested: Amikacin (AMK), Gentamicin (GEN), Tobramycin (TOB), Imipenem (IMP), Meropenem (MEM), Ceftazidime (CAZ), Cefepime (FEP), Ciprofloxacin
(CIP), Levofloxacin (LVX), Aztreonam (ATM), Piperacilin/Tazobactam (TZP), Colistin (COL), Fosfomycin (FOS), Imipenem-EDTA (IMP-EDTA). Results are indicated as S
sensitive, I intermediate, R non-susceptibility, Neg negative, Pos positive, - not applicable.
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sequence the mutL gene. All of the clinical isolates stud-
ied, except PaC46 and PaC49, were related with a simi-
larity between 98.5 - 100%. PaC46 and PaC49,
belonged to the same clonal complex and shared a
99.8% similarity between them, less than 95.8% with the
other clinical isolates and 95.7% with P. aeruginosa PA7,
considered to be an outlier of the species [15]. The cor-
responding genes of P. aeruginosa PA7 and PAO1 have a
similarity of 91.6%, and this percentage is lower when
other species of the genus were considered. A SplitsTree
was constructed with all of the isolates analysed
(Figure 2), and recombination was observed. The most
abundant sequence types observed were ST-175, ST-235
and ST-253.
Patients and antibiotic resistance pattern
Thirty-five isolates were single isolates (one per patient),
and, in seven patients, more than one isolate of P.
aeruginosa was obtained during the two-month period
studied (patients 1 and 8, four isolates each; patients 6,Table 3 Genetic diversity of the selected loci among the Pseu
No of
isolates
Locus Fragment
length (bp)
No. of
alleles
Gene diversity
± SD pol
56 acsA 390 20 0.904 ± 0.027
56 aroE 498 10 0.827 ± 0.025
56 guaA 373 15 0.868 ± 0.034
54 mutL 442 14 0.764 ± 0.055
56 nuoD 366 6 0.642 ± 0.048
56 ppsA 370 14 0.879 ± 0.024
56 trpE 443 15 0.876 ± 0.0239, 29, 32 and 38, two isolates each) (see Table 1). In two
patients (9 and 38), all of the isolates studied belonged
to the same ST and had the same antibiotic resistance
profile. Isolates with different STs were isolated from
three patients (patients 1, 6 and 8). Four isolates were
isolated from patient 1 during the time of the study:
PaC1 and PaC52 from a wound sample, and PaC49 and
PaC51 from rectal smear. PaC1 and PaC52, were isolated
with one month of difference, and belonged to the same
ST and showed the same antibiotic resistance profile
with the exception of gentamicin (intermediate suscepti-
bility). PaC49 and PaC51 were assigned to different STs
and showed differences in the antibiotic resistance pro-
file. Patient 6 showed the same antibiotic profile (with
the exception of meropenem). Four isolates with slight
differences in the antibiotic profile were recovered from
patient 8 (PaC10 and PaC19 from urine samples were
isolated with three days of difference, PaC32 from a rec-
tal smear and PaC40 was of respiratory origin). Isolate
PaC10 was assigned to a different ST based on differ-
ences in guaA allele, although it belonged to the samedomonas aeruginosa isolates analysed in this study
No. of
ymorphic sites
Avg. number of nucleotide
differences
Nucleotide
diversity ± SD
23 5.15325 0.01321 ± 0.00095
69 9.10909 0.01829 ± 0.00507
14 2.62013 0.00702 ± 0.00062
28 3.16702 0.00717 ± 0.00169
11 1.52922 0.00418 ± 0.00081
39 4.61364 0.01247 ± 0.00347
19 4.50260 0.01016 ± 0.00076
Figure 1 Concatenated phylogenetic tree showing the molecular evolutionary relationships of the seven genes analysed (acsA, aroE,
guaA, mutL, nuoD, ppsA and trpE) between the studied clinical Pseudomonas aeruginosa isolates. The antibiotic profile is indicated in the
figure: the MDR isolates are labelled in bold and the XDR isolates are indicated in bold and underlined. Clinical strains PaC7 and PaC16 are not
included in the phylogenetic tree. Asterisk mark (*) indicates the new sequence types described in this study.
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from patient 29 from two different samples (catheter and
blood); both of the isolates showed the same ST but
presented differences in their antibiotic profile and in the
production of MBLs, as detected by phenotypic methods.
Two isolates of patient 32 obtained from different origins
with two weeks of difference showed differences in
piperacilin/tazobactam-susceptibility, but belonged to the
same ST (see Table 1 and 2).
Population structure and susceptibility to antibiotics
From the 56 isolates analysed, 23 were non-MDR and 33
were multiresistant (MDR or XDR). The non-MDR iso-
lates were singleton STs, with the exception of ST-235
and ST-253. From the 56 isolates, 32 isolates werecarbapenem-non-susceptible (57.1%) and 15.6% of them
were MBL-positive. From those isolates, one was non-
susceptible to only imipenem, and thirty-one were non-
susceptible to both (isolate PaC16 showed intermediate
resistance to meropenem). The 32 carbapenem-non-
susceptible isolates were distributed into 15 sequence
types: ST-175 (12 isolates), ST-235 (3), ST-179 (2),
ST-253 (2), ST-274 (2), ST-108 (1), and ST-499 (1), and
eight new sequence types (seven singletons and one with
two isolates). Only four of these types (ST-175, ST-235,
ST-253 and ST-274) were also described previously in
the study of 16 Spanish hospitals [16].
No relations statistically significant could be established
in our study between antibiotic resistance and other vari-
ables as sex, age of patients, sample origin or STs, probably
Figure 2 SplitsTree showing the distribution of all of the sequence types obtained for the clinical Pseudomonas aeruginosa isolates
studied. The SplitsTree was based on the analysis of the allelic profiles of the acsA, aroE, guaA, mutL, nuoD, ppsA and trpE genes. The MDR
isolates are labelled in bold and the XDR isolates are indicated in bold and underlined. The sequence types represented by more than one isolate
are indicated in italic font. Asterisk mark (*) indicates the new sequence types described in this study.
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significant association was observed between the prevalent
ST (ST-175) and multiresistant isolates (p = 0.003).
Diversity analysis
To assess the extent of the diversity analysed in the
study, a rarefaction curve was constructed. Despite the
high diversity of the sequence types, the number of dif-
ferent sequence types referred to the number of isolates
analysed did not reach a saturation curve, indicating that
the diversity was higher than detected, a finding that
was confirmed when the coverage index (C) was calcu-
lated (51%). Additional isolates should be analysed to as-
certain the population structure of clinical P. aeruginosa
present in our hospital completely. Diversity was evalu-
ated using the Dominance (D), Shannon (H), Simpson
and Evenness indices, and the values obtained for each
index (0.075, 3.087, 0.925 and 0.684, respectively) indi-
cate a highly diverse sample. However, when only the
diversity of the multiresistant isolates (MDR and XDR)
were considered, a softer saturation curve was detected
and the coverage index was higher (62.5%), indicating
that the diversity was better screened. This result wasalso supported by the diversity indices (D of 0.1621,
H of 2.303, Simpson of 0.8379 and Evenness of 0.6255).
Discussion
The role of P. aeruginosa as a pathogen and its implica-
tion in nosocomial outbreaks has been widely studied.
The present study was focused on the analysis of the
population structure and diversity of P. aeruginosa
clinical isolates randomly chosen from their different
patterns of antibiotic resistance in a single hospital. The
isolates include different antibiotic non-susceptibility
profiles (21.4% MDR, 37.5% XDR and 41.1% non-MDR).
The MLST analysis showed a high diversity, as reported
in other previous studies. The 56 isolates were grouped
into 32 different sequence types, 12 sequence types that
were previously described (including 34 isolates) and 20
new ones (including 22 isolates). The singleton sequence
types (26 isolates) corresponded mainly to the non-MDR
isolates (16 isolates). Twenty-two of the isolates corres-
ponded to new sequence types (not previously defined) of
which 12 isolates were non-MDR, 6 isolates were MDR
and 4 isolates were XDR. The clinical isolates studied
showed a variable number of polymorphic sites and alleles,
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remarkable that we found the presence of new alleles
(not previously described) of four genes, acsA, aroE, mutL
and ppsA.
The analysis of the seven loci demonstrated that the
prevalent STs were ST-175, ST-235 and ST-253. ST-175
is widely distributed worldwide [17] and is the isolate
most frequently isolated in this study, with twelve
isolates obtained from eight patients. This ST is also the
most prevalent in the studies of García-Castillo et al.
and Cholley et al. [16,17]. ST-175 has been reported as a
contaminant of the hospital environment, a coloniser of
respiratory secretions in cystic fibrosis patients, and has
been associated with the multiresistant isolates of
P. aeruginosa. All of the isolates included in this group
were multiresistant (eleven XDR isolates and one MDR)
and were sensitive to colistin, 90% to amikacin, 37% to
aztreonam and nearly 10% to ceftazidime and cefepime.
All of the isolates were resistant to the other antibiotics
tested, and only one of them was MBL positive.
ST-235 is the second most frequently isolated
sequence type, with six isolates (from five patients); four
isolates were XDR, one isolate was MDR, and another
was non-MDR. This ST has been involved in the dissem-
ination of the genes encoding MBLs and has been asso-
ciated to multiple resistance mechanisms [18], although
Cholley et al. described strains with the same ST and
none of them was MBL-positive [17]. Three of our five
isolates were non-MBLs producers. In a previous study
performed in another Majorcan hospital, ST-235 has
been described as a VIM-13 producing β-lactamase
[19]. ST-179, previously described in Mallorca as VIM-2
producer, was also MBL-positive [19].
The third most abundant sequence type was ST-253,
with four isolates. These isolates were isolated from two
patients; two isolates were MDR, and two were non-MDR.
Only one isolate was colistin-resistant, corresponding to
ST-244 reported previously in Korea as the isolate most
frequently colistin non-susceptible and sensitive to other
antibiotics [20]. Our isolate was isolated in a mixed culture
with Morganella morganii and Serratia marcescens, both
inherently resistant to colistin.
The high discriminatory power of the MLST profiling
allowed the differentiation among isolates obtained from
the same patient at different dates and sampling sites.
When the specimen was associated with the site of
infection, the sequence type or clonal complex obtained
and the antibiotic resistance profiles were the same.
Conclusions
The present results indicate that P. aeruginosa isolates
revealed a significant frequency of recombination and a
panmictic net-like population structure, as was suggested
by Kiewitz and Tümler [21]. The population structure ofclinical P. aeruginosa present in our hospital indicates the
coexistence of nonresistant and resistant isolates with the
same sequence type. The multiresistant isolates studied
are grouped in the prevalent sequence types found in
other Spanish hospitals and at the international level, and
the susceptible isolates correspond mainly to singleton
sequence types.
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